Michael Scully

Michael Scully serves as the Head of US Commercial at IBSA USA since August 2022, overseeing the Sales, Sales Operations, Marketing, and Market Access for both in-line brands and future pipeline products. Prior to this role, Scully was the US Commercial Director at Luye Lifesciences USA from September 2018 to August 2022, where responsibilities included leading the US Commercial strategy and managing the transition of Seroquel IR & XR alongside future product portfolios. Additional experience includes a tenure as Regional Sales Director at Vernalis Therapeutics and various roles at AstraZeneca, including US HCP Marketing Leader and Commercial Business Director. Scully holds an MBA in Marketing from the University of Connecticut School of Business and a BA in History from Saint Michael's College.